For example, it is now well known that MM patients show aberrant expression of hypoxia-inducible factors (HIF1α, HIF2) or vascular-endothelial growth factor (VEGF) in relation to the hypoxic status observed in the BM microenvironment [46]. Here, VEGFA is linked to Miyoshi myopathy.